한글목차

세계 세포 기반 어세이 시장 규모는 2034년까지 8.7%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

생명공학, 특히 유전체학, 단백질학, 세포생물학의 발전은 첨단 세포 기반 분석에 대한 수요를 촉진하는 데 매우 중요한 역할을 하고 있습니다. 이러한 기술 발전의 융합은 연구자들이 세포 기능, 신호 전달 경로 및 복잡한 분자 상호 작용의 복잡성을 더 깊이 파고들 수 있는 새로운 길을 열어주고 있습니다. 예를 들어, 생명공학은 2023년 의약품 매출에 3,040억 달러의 기여를 할 것으로 예상되며, 최근 몇 년동안 지속적으로 증가 추세에 있습니다. 이 수치는 2026년에는 5,050억 달러까지 확대될 것으로 예측됩니다. 이에 비해 같은 해에 기존 의약품 시장 규모는 6,810억 달러에 달할 것으로 예상됩니다. 또한, 세계 생명공학 부문은 암 분야에서 약 39%라는 높은 점유율을 보이며 성장하고 있습니다. 이는 암 치료와 치료제 개발에 대한 관심과 투자가 얼마나 큰지 알 수 있는 대목입니다.

유전체학 분야는 하이스루풋 시퀀싱 기술의 등장으로 놀라운 발전을 이루었고, 연구자들은 전례 없는 속도와 정확도로 전체 게놈을 분석할 수 있게 되었습니다. 이러한 풍부한 유전정보는 질병의 분자적 기초를 이해하고 잠재적인 치료 표적을 식별하기 위한 기반이 되고 있습니다. 유전체학과 함께 세포 기반 분석은 이러한 유전적 지식을 활용하여 특정 유전자나 돌연변이가 세포 기능에 어떤 영향을 미치는지 연구함으로써 보다 타겟이 명확한 맞춤형 의약품 개발 전략의 길을 열어주고 있습니다.

세계 세포 기반 어세이(Cell Based Assay) 시장을 조사했으며, 시장 개요, 시장 성장에 영향을 미치는 요인과 시장 기회 분석, 시장 규모 추이 및 예측, 각 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 보고서 개요

제2장 주요 요약

제3장 시장 개요

• 주요 조사 결과
• 시장 역학
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
• COVID-19의 영향 분석
• Porter의 Five Forces 분석
• PEST 분석

제4장 세포 기반 어세이 시장 분석 : 제품별

• 주요 조사 결과
• 시장의 매력 지수
• 시장 규모 추이와 예측
• 기기
  • 마이크로플레이트
  • 마이크로플레이트 리더
  • 액체 처리 시스템
  • 인큐베이터
  • 현미경
  • 기타
• 소모품
  • 시약
  • 어세이 키트
  • 세포주
  • 프로브 및 라벨
  • 기타
• 소프트웨어
• 서비스
  • 시장 규모 추이와 예측 : 지역별
  • 시장 점유율 : 지역별

제5장 세포 기반 어세이 시장 분석 : 용도별

• 주요 조사 결과
• 시장의 매력 지수
• 시장 규모 추이와 예측
• Drug Discovery
• 기초 조사
• ADME 연구
• 독물학
• 기타
  • 시장 규모 추이와 예측 : 지역별
  • 시장 점유율 : 지역별

제6장 세포 기반 어세이 시장 분석 : 최종사용자별

• 주요 조사 결과
• 시장의 매력 지수
• 시장 규모 추이와 예측
• 제약 및 바이오테크놀러지 기업
• 학술기관
• CRO
• 기타
  • 시장 규모 추이와 예측 : 지역별
  • 시장 점유율 : 지역별

제7장 세포 기반 어세이 시장 분석 : 지역별

• 주요 조사 결과
• 시장 규모 추이와 예측

제8장 북미의 세포 기반 어세이 시장 분석

제9장 유럽의 세포 기반 어세이 시장 분석

제10장 아시아태평양의 세포 기반 어세이 시장 분석

제11장 라틴아메리카의 세포 기반 어세이 시장 분석

제12장 중동 및 아프리카의 세포 기반 어세이 시장 분석

제13장 기업 개요

• 경쟁 구도
• 전략적 전망
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• BioVision Inc.
• Charles River Laboratories
• Cisbio(Revvity)
• Danaher Corporation
• DiscoverX(Eurofins)
• F. Hoffmann-La Roche Ltd
• GE HealthCare
• InSphero
• Merck KGaA
• BioAgilytix Labs LLC
• Thermo Fisher Scientific Inc.

제14장 결론·추천 사항

• Visiongain의 결론
• 참여 기업을 위한 추천 사항

영문목차

The global Cell-Based Assays market is projected to grow at a CAGR of 8.7% by 2034 .

“The Cell-Based Assays Market Report 2024-2034”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Advancements in Biotechnology Industry Projected to Boost Industry Growth

Advances in biotechnology, specifically in genomics, proteomics, and cell biology, are playing a pivotal role in propelling the demand for sophisticated cell-based assays. The convergence of these technological advancements has opened new avenues for researchers, enabling them to delve deeper into the intricacies of cellular functions, signaling pathways, and complex molecular interactions. For instance, in 2023, biotechnology contributed $304 billion to drug revenues, demonstrating a consistent upward trend over recent years. Projections indicate that this figure is anticipated to climb to $505 billion by 2026. In comparison, the conventional drug market is expected to reach a value of $681 billion in the same year. In addition, the global biotechnology sector experienced the prevalence of oncology, holding a significant share of around 39%. This highlights the substantial attention and investment directed toward the advancement of cancer treatments and therapies.

The field of genomics has witnessed remarkable progress with the advent of high-throughput sequencing technologies, allowing researchers to analyze entire genomes with unprecedented speed and precision. This wealth of genetic information has provided a foundation for understanding the molecular basis of diseases and identifying potential therapeutic targets. In tandem with genomics, cell-based assays capitalize on this genetic knowledge to study how specific genes and mutations influence cellular functions, paving the way for more targeted and personalized drug development strategies.

High Cost Associated with Cell-Based Assays Likely to Challenge Industry Growth

The development and deployment of sophisticated cell-based assays impose a considerable financial burden, acting as a formidable barrier for smaller research institutions and laboratories grappling with limited budgets. The principal contributors to these substantial upfront costs encompass the acquisition of advanced equipment, specialized reagents, and the maintenance of skilled personnel for assay design and execution. State-of-the-art technologies, such as high-content imaging systems and automated liquid handling platforms, come with hefty price tags, making them financially daunting for smaller institutions. The demand for specialized reagents, tailored to the intricacies of sophisticated assays, further escalates overall costs.

What Questions Should You Ask before Buying a Market Research Report?

• How is the Cell-Based Assays market evolving?
• What is driving and restraining the Cell-Based Assays market?
• How will each Cell-Based Assays submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
• How will the market shares for each Cell-Based Assays submarket develop from 2024 to 2034?
• What will be the main driver for the overall market from 2024 to 2034?
• Will leading Cell-Based Assays markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Cell-Based Assays projects for these leading companies?
• How will the industry evolve during the period between 2024 and 2034? What are the implications of Cell-Based Assays projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the Cell-Based Assays market?
• Where is the Cell-Based Assays market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Cell-Based Assays market today, and over the next 10 years:

• Our 314-page report provides 114 tables and 170 charts/graphs exclusively to you
• The report highlights key lucrative areas in the industry so you can target them - NOW
• It contains in-depth analysis of global, regional and national sales and growth
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Cell-Based Assays market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares
• You will find original analyses, with business outlooks and developments
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Cell-Based Assays prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Product

• Instruments
  • Microplates
  • Microplate Reader
  • Liquid Handling System
  • Incubator
  • Microscope
  • Others

• Consumables
  • Reagents
  • Assay Kits
  • Cell Lines
  • Probes & Labels
  • Others

• Software
• Services

Application

• Drug Discovery
• Basic Research
• ADME Studies
• Toxicology
• Others

End-User

• Pharmaceutical & Biotechnology Companies
• Academic Institutes
• CROs
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 24 leading national markets:

North America

• U.S
• Canada

Europe

• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific

• Japan
• China
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America

MEA

• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Cell-Based Assays Market 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report:

Overall world revenue for Cell-Based Assays Market, 2024 to 2034 in terms of value the market will surpass US$18,800 million in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Cell-Based Assays Market, 2024 to 2034 report help you?

In summary, our 310+ page report provides you with the following knowledge:

• Revenue forecasts to 2034 for Cell-Based Assays Market, 2024 to 2034 Market, with forecasts for product, application and end-user, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2034 for five regional and 24 key national markets - See forecasts for the Cell-Based Assays Market 2024 to 2034 in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the Cell-Based Assays Market 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Cell-Based Assays Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

• 1.1 Objectives of the Study
• 1.2 Introduction to Cell-Based Assays Market
• 1.3 What This Report Delivers
• 1.4 Why You Should Read This Report
• 1.5 Key Questions Answered by This Analytical Report
• 1.6 Who is This Report for?
• 1.7 Methodology
  • 1.7.1 Market Definitions
  • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.7.3 Data Validation
    • 1.7.3.1 Primary Research
    • 1.7.3.2 Secondary Research
• 1.8 Frequently Asked Questions (FAQs)
• 1.9 Associated Visiongain Reports
• 1.10 About Visiongain

2 Executive Summary

3 Market Overview

• 3.1 Key Findings
• 3.2 Market Dynamics
  • 3.2.1 Market Driving Factors
    • 3.2.1.1 Increased Need of Cell-Based Assays in Drug Discovery and Development
    • 3.2.1.2 Advances in Biotechnology
    • 3.2.1.3 Growing Demand for Precision Medicine Impacting the Cell-Based Assays Market Positively
    • 3.2.1.4 Increasing Funding for Cell-based Research
    • 3.2.1.5 Rising Prevalence of Chronic Diseases
  • 3.2.2 Market Restraining Factors
    • 3.2.2.1 High Cost Associated with Cell-Based Assays
    • 3.2.2.2 Technical Complexity of Cell-Based Assays
    • 3.2.2.3 Lack of Standardization
  • 3.2.3 Market Opportunities
    • 3.2.3.1 Growing Adoption of Label-Free Cell-Based Assays
    • 3.2.3.2 3D Cell Culture Models as a Cornerstone of Advanced Assays
    • 3.2.3.3 High-Throughput Screening Driving Demand for Cell-Based Assays
• 3.3 COVID-19 Impact Analysis
• 3.4 Porter's Five Forces Analysis
  • 3.4.1 Bargaining Power of Suppliers
  • 3.4.2 Bargaining Power of Buyers
  • 3.4.3 Competitive Rivalry
  • 3.4.4 Threat from Substitutes
  • 3.4.5 Threat of New Entrants
• 3.5 PEST Analysis

4 Cell-Based Assays Market Analysis by Product

• 4.1 Key Findings
• 4.2 Product Segment: Market Attractiveness Index
• 4.3 Cell-Based Assays Market Size Estimation and Forecast by Product
• 4.4 Instruments
  • 4.4.1 Market Size by Region, 2024-2034 (US$ Million)
  • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.4.3 Microplates
    • 4.4.3.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.4.3.2 Market Share by Region, 2024 & 2034 (%)
  • 4.4.4 Microplate Reader
    • 4.4.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.4.5 Liquid Handling System
    • 4.4.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.4.5.2 Market Share by Region, 2024 & 2034 (%)
  • 4.4.6 Incubator
    • 4.4.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.4.6.2 Market Share by Region, 2024 & 2034 (%)
  • 4.4.7 Microscope
    • 4.4.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.4.7.2 Market Share by Region, 2024 & 2034 (%)
  • 4.4.8 Others
    • 4.4.8.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.4.8.2 Market Share by Region, 2024 & 2034 (%)
• 4.5 Consumables
  • 4.5.1 Market Size by Region, 2024-2034 (US$ Million)
  • 4.5.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5.3 Reagents
    • 4.5.3.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.5.3.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5.4 Assay Kits
    • 4.5.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5.5 Cell Lines
    • 4.5.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.5.5.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5.6 Probes & Labels
    • 4.5.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.5.6.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5.7 Others
    • 4.5.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.5.7.2 Market Share by Region, 2024 & 2034 (%)
• 4.6 Software
  • 4.6.1 Market Size by Region, 2024-2034 (US$ Million)
  • 4.6.2 Market Share by Region, 2024 & 2034 (%)
• 4.7 Services
  • 4.7.1 Market Size by Region, 2024-2034 (US$ Million)
  • 4.7.2 Market Share by Region, 2024 & 2034 (%)

5 Cell-Based Assays Market Analysis by Application

• 5.1 Key Findings
• 5.2 Application Segment: Market Attractiveness Index
• 5.3 Cell-Based Assays Market Size Estimation and Forecast by Application
• 5.4 Drug Discovery
  • 5.4.1 Market Size by Region, 2024-2034 (US$ Million)
  • 5.4.2 Market Share by Region, 2024 & 2034 (%)
• 5.5 Basic Research
  • 5.5.1 Market Size by Region, 2024-2034 (US$ Million)
  • 5.5.2 Market Share by Region, 2024 & 2034 (%)
• 5.6 ADME Studies
  • 5.6.1 Market Size by Region, 2024-2034 (US$ Million)
  • 5.6.2 Market Share by Region, 2024 & 2034 (%)
• 5.7 Toxicology
  • 5.7.1 Market Size by Region, 2024-2034 (US$ Million)
  • 5.7.2 Market Share by Region, 2024 & 2034 (%)
• 5.8 Others
  • 5.8.1 Market Size by Region, 2024-2034 (US$ Million)
  • 5.8.2 Market Share by Region, 2024 & 2034 (%)

6 Cell-Based Assays Market Analysis by End-users

• 6.1 Key Findings
• 6.2 End-users Segment: Market Attractiveness Index
• 6.3 Cell-Based Assays Market Size Estimation and Forecast by End-users
• 6.4 Pharmaceutical & Biotechnology Companies
  • 6.4.1 Market Size by Region, 2024-2034 (US$ Million)
  • 6.4.2 Market Share by Region, 2024 & 2034 (%)
• 6.5 Academic Institutes
  • 6.5.1 Market Size by Region, 2024-2034 (US$ Million)
  • 6.5.2 Market Share by Region, 2024 & 2034 (%)
• 6.6 CROs
  • 6.6.1 Market Size by Region, 2024-2034 (US$ Million)
  • 6.6.2 Market Share by Region, 2024 & 2034 (%)
• 6.7 Others
  • 6.7.1 Market Size by Region, 2024-2034 (US$ Million)
  • 6.7.2 Market Share by Region, 2024 & 2034 (%)

7 Cell-Based Assays Market Analysis by Region

• 7.1 Key Findings
• 7.2 Regional Market Size Estimation and Forecast

8 North America Cell-Based Assays Market Analysis

• 8.1 Key Findings
• 8.2 North America Cell-Based Assays Market Attractiveness Index
• 8.3 North America Cell-Based Assays Market by Country, 2024, 2029 & 2034 (US$ Million)
• 8.4 North America Cell-Based Assays Market Size Estimation and Forecast by Country
• 8.5 North America Cell-Based Assays Market Size Estimation and Forecast by Product
• 8.6 North America Cell-Based Assays Market Size Estimation and Forecast by Application
• 8.7 North America Cell-Based Assays Market Size Estimation and Forecast by End-users
• 8.8 U.S. Cell-Based Assays Market Analysis
• 8.9 Canada Cell-Based Assays Market Analysis

9 Europe Cell-Based Assays Market Analysis

• 9.1 Key Findings
• 9.2 Europe Cell-Based Assays Market Attractiveness Index
• 9.3 Europe Cell-Based Assays Market by Country, 2024, 2029 & 2034 (US$ Million)
• 9.4 Europe Cell-Based Assays Market Size Estimation and Forecast by Country
• 9.5 Europe Cell-Based Assays Market Size Estimation and Forecast by Product
• 9.6 Europe Cell-Based Assays Market Size Estimation and Forecast by Application
• 9.7 Europe Cell-Based Assays Market Size Estimation and Forecast by End-users
• 9.8 Germany Cell-Based Assays Market Analysis
• 9.9 France Cell-Based Assays Market Analysis
• 9.10 UK Cell-Based Assays Market Analysis
• 9.11 Italy Cell-Based Assays Market Analysis
• 9.12 Spain Cell-Based Assays Market Analysis
• 9.13 Russia Cell-Based Assays Market Analysis
• 9.14 Rest of Europe Cell-Based Assays Market Analysis

10 Asia Pacific Cell-Based Assays Market Analysis

• 10.1 Key Findings
• 10.2 Asia Pacific Cell-Based Assays Market Attractiveness Index
• 10.3 Asia Pacific Cell-Based Assays Market by Country, 2024, 2029 & 2034 (US$ Million)
• 10.4 Asia Pacific Cell-Based Assays Market Size Estimation .and Forecast by Country
• 10.5 Asia Pacific Cell-Based Assays Market Size Estimation and Forecast by Product
• 10.6 Asia Pacific Cell-Based Assays Market Size Estimation and Forecast by Application
• 10.7 Asia Pacific Cell-Based Assays Market Size Estimation and Forecast by End-users
• 10.8 Japan Cell-Based Assays Market Analysis
• 10.9 China Cell-Based Assays Market Analysis
• 10.10 India Cell-Based Assays Market Analysis
• 10.11 Australia Cell-Based Assays Market Analysis
• 10.12 South Korea Cell-Based Assays Market Analysis
• 10.13 Singapore Cell-Based Assays Market Analysis
• 10.14 Rest of Asia Pacific Cell-Based Assays Market Analysis

11 Latin America Cell-Based Assays Market Analysis

• 11.1 Key Findings
• 11.2 Latin America Cell-Based Assays Market Attractiveness Index
• 11.3 Latin America Cell-Based Assays Market by Country, 2024, 2029 & 2034 (US$ Million)
• 11.4 Latin America Cell-Based Assays Market Size .Estimation and Forecast by Country
• 11.5 Latin America Cell-Based Assays Market Size Estimation and Forecast by Product
• 11.6 Latin America Cell-Based Assays Market Size Estimation and Forecast by Application
• 11.7 Latin America Cell-Based Assays Market Size Estimation and Forecast by End-users
• 11.8 Brazil Cell-Based Assays Market Analysis
• 11.9 Mexico Cell-Based Assays Market Analysis
• 11.10 Argentina Cell-Based Assays Market Analysis
• 11.11 Colombia Cell-Based Assays Market Analysis
• 11.12 Rest of Latin America Cell-Based Assays Market Analysis

12 MEA Cell-Based Assays Market Analysis

• 12.1 Key Findings
• 12.2 MEA Cell-Based Assays Market Attractiveness Index
• 12.3 MEA Cell-Based Assays Market by Country, 2024, 2029 & 2034 (US$ Million)
• 12.4 MEA Cell-Based Assays Market Size Estimation and Forecast by Country
• 12.5 MEA Cell-Based Assays Market Size Estimation and Forecast by Product
• 12.6 MEA Cell-Based Assays Market Size Estimation and Forecast by Application
• 12.7 MEA Cell-Based Assays Market Size Estimation and Forecast by End-users
• 12.8 GCC Cell-Based Assays Market Analysis
• 12.9 South Africa Cell-Based Assays Market Analysis
• 12.10 Rest of MEA Cell-Based Assays Market Analysis

13 Company Profiles

• 13.1 Competitive Landscape, 2022
• 13.2 Strategic Outlook
• 13.3 Agilent Technologies, Inc.
  • 13.3.1 Company Snapshot
  • 13.3.2 Company Overview
  • 13.3.3 Financial Analysis
    • 13.3.3.1 Net Revenue, 2017-2022
    • 13.3.3.2 Regional Market Shares, 2022
    • 13.3.3.3 R&D, 2017-2022
  • 13.3.4 Product Benchmarking
  • 13.3.5 Strategic Outlook
• 13.4 Becton, Dickinson and Company
  • 13.4.1 Company Snapshot
  • 13.4.2 Company Overview
  • 13.4.3 Financial Analysis
    • 13.4.3.1 Net Revenue, 2017-2022
    • 13.4.3.2 R&D, 2017-2022
  • 13.4.4 Product Benchmarking
  • 13.4.5 Strategic Outlook
• 13.5 Bio-Rad Laboratories, Inc.
  • 13.5.1 Company Snapshot
  • 13.5.2 Company Overview
  • 13.5.3 Financial Analysis
    • 13.5.3.1 Net Revenue, 2017-2022
    • 13.5.3.2 Regional Market Share, 2022
    • 13.5.3.3 R&D, 2017-2022
  • 13.5.4 Product Benchmarking
  • 13.5.5 Strategic Outlook
• 13.6 BioVision Inc.
  • 13.6.1 Company Snapshot
  • 13.6.2 Company Overview
  • 13.6.3 Product Benchmarking
• 13.7 Charles River Laboratories
  • 13.7.1 Company Snapshot
  • 13.7.2 Company Overview
  • 13.7.3 Financial Analysis
    • 13.7.3.1 Net Revenue, 2017-2022
    • 13.7.3.2 Regional Market Share, 2022
  • 13.7.4 Product Benchmarking
• 13.8 Cisbio (Revvity)
  • 13.8.1 Company Snapshot
  • 13.8.2 Company Overview
  • 13.8.3 Product Benchmarking
  • 13.8.4 Strategic Outlook
• 13.9 Danaher Corporation
  • 13.9.1 Company Snapshot
  • 13.9.2 Company Overview
  • 13.9.3 Financial Analysis
    • 13.9.3.1 Net Revenue, 2017-2022
    • 13.9.3.2 Regional Market Share, 2022
    • 13.9.3.3 R&D, 2017-2022
  • 13.9.4 Product Benchmarking
  • 13.9.5 Strategic Outlook
• 13.10 DiscoverX (Eurofins)
  • 13.10.1 Company Snapshot
  • 13.10.2 Company Overview
  • 13.10.3 Product Benchmarking
  • 13.10.4 Strategic Outlook
• 13.11 F. Hoffmann-La Roche Ltd
  • 13.11.1 Company Snapshot
  • 13.11.2 Company Overview
  • 13.11.3 Financial Analysis
    • 13.11.3.1 Net Revenue, 2017-2022
    • 13.11.3.2 R&D, 2017-2022
  • 13.11.4 Product Benchmarking
  • 13.11.5 Strategic Outlook
• 13.12 GE HealthCare
  • 13.12.1 Company Snapshot
  • 13.12.2 Company Overview
  • 13.12.3 Financial Analysis
    • 13.12.3.1 Net Revenue, 2017-2022
    • 13.12.3.2 Regional Market Share, 2022
    • 13.12.3.3 R&D, 2017-2022
  • 13.12.4 Product Benchmarking
  • 13.12.5 Strategic Outlook
• 13.13 InSphero
  • 13.13.1 Company Snapshot
  • 13.13.2 Company Overview
  • 13.13.3 Product Benchmarking
• 13.14 Merck KGaA
  • 13.14.1 Company Snapshot
  • 13.14.2 Company Overview
  • 13.14.3 Financial Analysis
    • 13.14.3.1 Net Revenue, 2017-2022
    • 13.14.3.2 Regional Market Share, 2022
    • 13.14.3.3 R&D, 2017-2022
  • 13.14.4 Product Benchmarking
• 13.15 BioAgilytix Labs LLC
  • 13.15.1 Company Snapshot
  • 13.15.2 Company Overview
  • 13.15.3 Product Benchmarking
• 13.16 Thermo Fisher Scientific Inc.
  • 13.16.1 Company Snapshot
  • 13.16.2 Company Overview
  • 13.16.3 Financial Analysis
    • 13.16.3.1 Net Revenue, 2017-2022
    • 13.16.3.2 Regional Market Share, 2022
    • 13.16.3.3 R&D, 2017-2022
  • 13.16.4 Product Benchmarking

14 Conclusion and Recommendations

• 14.1 Concluding Remarks from Visiongain
• 14.2 Recommendations for Market Players